Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79329486 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2021-11-10 | Application Filed |
2021-12-23 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-12-23 | Status: Live/Pending |
2022-01-03 | Transaction Date |
Owner: | ![]() |
Address | 32 Higashikujyo Kawanishi-cho, Minami-ku, Kyoto-shi Kyoto 601-8014 JP |
Legal Entity Type | Corporation |
Legal Entity State | JP |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0051 | Cosmetics for medical use; patch-shapedpharmaceutical preparations; sheet-shaped pharmaceutical preparations; pharmaceutical preparations |
GS0051 | Cosmetics for medical use, namely, medicated cosmetics; patch-shaped pharmaceutical preparations in the nature of transdermal patches for stimulating hair growth; patch-shaped pharmaceutical preparations in the nature of transdermal patches featuring topical anesthetics; patch-shaped pharmaceutical preparations in the nature of transdermal patches for treating facial wrinkles and the treatment of damaged skin; patch-shaped pharmaceutical preparations in the nature of transdermal patches for use in the treatment of skin disorders; sheet-shaped pharmaceutical preparations in the nature of transdermal patches for stimulating hair growth; sheet-shaped pharmaceutical preparations in the nature of transdermal patches featuring topical anesthetics; sheet-shaped pharmaceutical preparations in the nature of transdermal patches for treating facial wrinkles and the treatment of damaged skin; sheet-shaped pharmaceutical preparations in the nature of transdermal patches for use in the treatment of skin disorders |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-12-23 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-01-03 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-01-07 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2022-03-04 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-03-07 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-03-08 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2022-04-07 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-04-07 | 8 RFCS P: |
REFUSAL PROCESSED BY IB | 2022-04-25 | 9 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-09-19 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-09-19 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-09-20 | 12 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2022-10-17 | 13 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2022-10-17 | 14 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-10-17 | 15 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-01-16 | 16 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-01-16 | 17 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-01-16 | 18 TEME I:Incoming Correspondence |
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | 2023-01-23 | 19 RRDX W: |
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | 2023-01-23 | 20 RDX1 O:Outgoing Correspondence |
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | 2023-01-23 | 21 RDX3 O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2023-02-03 | 22 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-03 | 23 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-03 | 24 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-03-07 | 25 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-03-22 | 26 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2023-03-22 | 27 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-03-22 | 28 OPNS P: |
PUBLISHED FOR OPPOSITION | 2023-04-11 | 29 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-04-11 | 30 NPUB E:E-Mail |
NOTIFICATION PROCESSED BY IB | 2023-04-13 | 31 GPNX P: |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2023-05-24 | 32 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2023-05-24 | 33 OPNS P: |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2023-06-11 | 34 OPNX P: |
REGISTERED-PRINCIPAL REGISTER | 2023-06-27 | 35 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-06-27 | 36 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2023-09-27 | 37 FICR P: |
FINAL DISPOSITION PROCESSED | 2023-09-27 | 38 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2023-09-28 | 39 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-10-24 | 40 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.